University of Miami McKnight Brain Institute is a clinical research site located in Miami, Florida, United States 33136.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Miami McKnight Brain Institute has participated in 3 clinical trials.
Therapeutic areas: Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, Coronary Artery Disease.
Sponsors: Alexion Pharmaceuticals, Inc., Boston Scientific Corporation.
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Miami McKnight Brain Institute has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Miami McKnight Brain Institute has 3 clinical trials on record. Their work covers Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, Coronary Artery Disease.
University of Miami McKnight Brain Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.